GSS genetic signatures limited

The point company has not been onto PR has made it difficult for...

  1. 424 Posts.
    lightbulb Created with Sketch. 262

    The point company has not been onto PR has made it difficult for continuous SP rise. Last quarterly should have news of AU enteric site open, FDA application, new partner overseas and winter flu testing sales, due in 2 weeks time. Both FY22 report and FY23 outlook should be bright and take SP upwards from here.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
38.5¢
Change
0.000(0.00%)
Mkt cap ! $87.44M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 28000 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 20000 1
View Market Depth
Last trade - 09.59am 17/07/2025 (20 minute delay) ?
GSS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.